Lateral internal sphincterotomy (LIS) is a minimally invasive procedure used to treat chronic anal fissures. It involves cutting the internal sphincter muscle, which is located between the rectum and the anus. This procedure is used to reduce spasm and pain, as well as to promote healing of the fissure. While it is an effective treatment option, it is not without risks. This article will explore the benefits and risks of LIS in order to help doctors better understand this procedure and its potential impact on their patients.
Lateral internal sphincterotomy (LIS) is a surgical procedure used to treat chronic anal fissures. It involves cutting the internal sphincter muscle, which is located between the rectum and the anus. This procedure is used to reduce spasm and pain, as well as to promote healing of the fissure. The procedure is typically performed under general anesthesia. During the procedure, the surgeon makes a small incision in the sphincter muscle and then divides it in two. This reduces the tension in the muscle, which helps to reduce spasm and pain, as well as to promote healing of the fissure. The procedure is typically performed as an outpatient procedure and takes about 30 minutes to complete. After the procedure, patients typically experience some pain, bleeding, and swelling for a few days.
Lateral internal sphincterotomy is an effective treatment option for chronic anal fissures. The procedure helps to reduce spasm and pain, as well as to promote healing of the fissure. It is also a minimally invasive procedure, which means that it has a shorter recovery time and fewer risks than more invasive surgical procedures. The procedure is also relatively safe. The risks associated with the procedure are typically minor and include pain, bleeding, infection, and swelling. The procedure is also relatively cost-effective, as it is typically performed as an outpatient procedure.
Although the procedure is relatively safe, there are some risks associated with LIS. These risks include pain, bleeding, infection, and swelling. In rare cases, the procedure can also cause damage to the nerves or muscles in the area, which can lead to incontinence or other complications. Additionally, the procedure can cause scarring, which can lead to narrowing of the anal canal.
Lateral internal sphincterotomy is a minimally invasive procedure used to treat chronic anal fissures. The procedure is effective in reducing spasm and pain, as well as promoting healing of the fissure. It is also relatively safe and cost-effective. However, there are some risks associated with the procedure, including pain, bleeding, infection, swelling, nerve or muscle damage, and scarring. Doctors should weigh the risks and benefits of LIS when considering this procedure for their patients.
1.
Vaccine shows promise for pancreatic cancer, study finds
2.
After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.
3.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
4.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
5.
Tumor characteristics found to differ for melanomas in children, teens and young adults
1.
The Ins and Outs of Glossectomy: What You Need to Know
2.
The Pros and Cons of Steroid Therapy for ITP
3.
Comprehensive Applications in Hematology for Better Care
4.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
5.
Physical Performance Recovery in Patients With Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Efficient Management of First line ALK-rearranged NSCLC - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation